Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: A prospective, double-blind, randomized, placebo-controlled study

Annals of Thoracic Surgery

Volumn 64, Issue 4, 1997, Pages 1113-1119

  Pfisterer, Matthias E ^a   Klöter Weber, Uta C D ^a   Huber, Maurus ^a   Osswald, Stefan ^a   Buser, Peter T ^a   Skarvan, Karl ^a   Stulz, Peter M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SOTALOL;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR CONDUCTION; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HEART FAILURE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR TACHYCARDIA; VERTIGO;

AGED; ANTI-ARRHYTHMIA AGENTS; AORTIC VALVE; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SOTALOL; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0343471391     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00804-7     Document Type: Article

References (24)

1. Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis. 31:1989;367-378.
2. Crosby LH, Pifalo WB, Woll KR, Burkholder JA. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 66:1990;1520-1522.
3. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 56:1993;536-549.
4. Rousou JA, Meeran MK, Engelman RH, Breyer RH, Lemeshow S. Does the type of venous drainage or cardioplegia affect postoperative conduction and atrial arrhythmias? Circulation. 72:(Suppl 2):1985;259-263.
5. Mendes LA, Connelly GP, McKenney PA, Podrid PJ, Cupples LA. Right coronary artery stenosis an independent predictor of atrial fibrillation after coronary artery bypass surgery . J Am Coll Cardiol. 25:1995;198-202.
6. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg. 101:1991;56-65.
7. Weiner B, Rheinlander HF, Decker EL, Cleveland RJ. Digoxin prophylaxis following coronary artery bypass surgery. Clin Pharm. 5:1986;55-58.
8. Martinussen HJ, Lolk A, Szezepanski C, Alstrup P. Supraventricular tachyarrhythmias after coronary bypass surgery - a double blind randomized trial of prophylactic low dose propranolol. Thorac Cardiovasc Surg. 36:1988;206-207.
9. Williams DB, Misbach GA, Kruse AP, Ivey TD. Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial infarction. A randomized trial. J Thorac Cardiovasc Surg. 90:1985;592-596.
10. Davison R, Hartz R, Kaplan K, Parker M, Feiereisel P, Michaelis L. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil a randomized, double-blind trial . Ann Thorac Surg. 39:1985;336-339.
11. Gentili C, Giordano F, Alois A, Massa E, Bianconi L. Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery. Am Heart J. 123:1992;1225-1228.
12. Wafa SS, Ward DE, Parker DJ, Camm AJ. Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting. Am J Cardiol. 63:1989;1058-1064.
13. Laub GW, Janeira L, Muralidharan S, et al. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting a prospective, double-blind, randomized, placebo-controlled pilot study . Crit Care Med. 21:1993;1474-1478.
14. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery a randomised, double blind, placebo controlled trial . Br Heart J. 70:1993;56-60.
15. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone results of a prospective, placebo-controlled study . Am Heart J. 121:1991;89-95.
16. Nyström U, Edvardsson N, Berggren H, Pizzarelli GP, Rådegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg. 41:1993;34-37.
17. Jacquet L, Evenepoel M, Marenne F, et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 8:1994;431-436.
18. Suttorp MJ, Kingma JH, Tjon-Joe-Gin RM, et al. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg. 100:1990;921-926.
19. Suttorp MJ, Kingma J, Peels HO, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol. 68:1991;1163-1169.
20. Frost L, Mølgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Bloch Thomsen PE. Atrial fibrillation and flutter after coronary artery bypass surgery epidemiology, risk factors and preventive trials . Int J Cardiol. 36:1992;253-261.
21. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med. 117:1992;141-150.
22. McKibbin JK, Pocock W, Barlow JM, Scottmillar RN, Obel IW. Sotalol, hypokalemia, syncope and torsade de pointes. Br Heart J. 51:1984;157-162.
23. Kalman JM, Munawar M, Howes LG, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg. 60:1995;1709-1715.
24. Waldo AL, Camm AJ, de Ruyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 348:1996;7-12.